The 11 most recent market catalysts affecting $RXO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 9, 2026
Corporate Catalyst
Bullish
Impact 75
RXO Says August Truckload Gross Profit Per Load Rose More Than 10% From July, Better Than Prior Outlook; Continues To Expect Q3 Truckload Volume Up Low-To-Mid Single Digit Percentage Year-Over-Year
This headline is a significant positive catalyst for RXO, indicating better-than-expected operational performance and a more optimistic outlook for the current quarter. The increas…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 55
UBS Maintains Neutral on RXO, Lowers Price Target to $23
UBS analyst Thomas Wadewitz maintained a 'Neutral' rating on RXO but lowered the price target from $26 to $23. This action signals a slightly diminished valuation expectation for t…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 55
TD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5
TD Cowen analyst Jason Seidl maintained a 'Sell' rating on RXO and lowered the price target from $19 to $17.5. This action signals a continued lack of confidence from a prominent a…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 55
Citigroup Maintains Neutral on RXO, Lowers Price Target to $23
Citigroup analyst Ariel Rosa has maintained a 'Neutral' rating on RXO but has notably reduced the price target from $30 to $23. This action indicates a more conservative valuation …
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 65
Citizens Upgrades RXO to Market Outperform, Announces $30 Price Target
Citizens analyst Jeff Kauffman upgraded RXO's rating from Market Perform to Market Outperform and established a new price target of $30. This analyst action is a positive catalyst …
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 85
RXO shares are trading higher after the company reported better-than-expected Q2 financial results.
RXO's outperformance in Q2 is a significant corporate catalyst, indicating strong company-specific execution and potentially a more favorable operating environment for the broader …
Jul 28, 2026
Corporate Catalyst
Bearish
Impact 75
RXO shares are trading lower after TD Cowen downgraded the stock from Hold to Sell rating and lowered its price target from $24 to $19.
This headline represents a significant corporate catalyst for RXO. Analyst downgrades, especially from 'Hold' to 'Sell' with a substantial price target cut, often signal a fundamen…
Jul 28, 2026
Corporate Catalyst
Bearish
Impact 65
TD Cowen Downgrades RXO to Sell, Lowers Price Target to $19
TD Cowen's downgrade of RXO from Hold to Sell, coupled with a significant price target reduction from $24 to $19, indicates a deteriorating outlook from this analyst firm. This act…
Jul 15, 2026
Market Technicals
Bullish
Impact 55
Truist Securities Maintains Buy on RXO, Raises Price Target to $30
Truist Securities analyst Lucas Servera has maintained a 'Buy' rating on RXO and raised the price target from $26 to $30. This action indicates an analyst's increased conviction in…
Jul 14, 2026
Corporate Catalyst
Neutral
Impact 65
BMO Capital Initiates Coverage On RXO with Outperform Rating, Announces Price Target of $35
BMO Capital has initiated coverage on RXO, assigning an 'Outperform' rating and a $35 price target. This event is significant as new analyst coverage, especially with a positive ra…
Jul 13, 2026
Corporate Catalyst
Bullish
Impact 65
Stifel Maintains Buy on RXO, Raises Price Target to $30
Stifel analyst J. Bruce Chan maintained a 'Buy' rating on RXO and significantly raised the price target from $22 to $30. This upgrade signals increased confidence in RXO's future p…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.